Angelo Gaffo, MD, FACP
University of Alabama at Birmingham
Birmingham, AL, United States
Disclosure(s): AVALO: Consultant (Ongoing)
Puja Khanna, MD, MPH (she/her/hers)
University of Michigan
Ann Arbor, Michigan, United States
Disclosure(s): Arthrosi: Grant/Research Support (Ongoing); Horizon/Amgen: Grant/Research Support (Ongoing); Olatec: Grant/Research Support (Ongoing); SOBI: Consultant (Ongoing)
Angelo Gaffo, MD, FACP
University of Alabama at Birmingham
Birmingham, AL, United States
Disclosure(s): AVALO: Consultant (Ongoing)
Puja Khanna, MD, MPH (she/her/hers)
University of Michigan
Ann Arbor, Michigan, United States
Disclosure(s): Arthrosi: Grant/Research Support (Ongoing); Horizon/Amgen: Grant/Research Support (Ongoing); Olatec: Grant/Research Support (Ongoing); SOBI: Consultant (Ongoing)
The session will highlight updates on clinical presentation, classification, and therapeutics of calcium pyrophosphate deposition disease (CPPD).
Speaker: Sara Tedeschi, MD, MPH – Brigham and Women's Hospital
Speaker: Tristan Pascart, MD,PhD (he/him/his) – Lille Catholic University